641 related articles for article (PubMed ID: 33684447)
1. Macrophages bind LDL using heparan sulfate and the perlecan protein core.
Ng CY; Whitelock JM; Williams H; Kim HN; Medbury HJ; Lord MS
J Biol Chem; 2021; 296():100520. PubMed ID: 33684447
[TBL] [Abstract][Full Text] [Related]
2. Heparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation.
Tran-Lundmark K; Tran PK; Paulsson-Berne G; Fridén V; Soininen R; Tryggvason K; Wight TN; Kinsella MG; Borén J; Hedin U
Circ Res; 2008 Jul; 103(1):43-52. PubMed ID: 18596265
[TBL] [Abstract][Full Text] [Related]
3. Macrophage plasma membrane chondroitin sulfate proteoglycan binds oxidized low-density lipoprotein.
Kaplan M; Aviram M
Atherosclerosis; 2000 Mar; 149(1):5-17. PubMed ID: 10704609
[TBL] [Abstract][Full Text] [Related]
4. Human monocyte-derived macrophages secrete two forms of proteoglycan-macrophage colony-stimulating factor that differ in their ability to bind low density lipoproteins.
Chang MY; Olin KL; Tsoi C; Wight TN; Chait A
J Biol Chem; 1998 Jun; 273(26):15985-92. PubMed ID: 9632647
[TBL] [Abstract][Full Text] [Related]
5. The glycosylation-dependent interaction of perlecan core protein with LDL: implications for atherosclerosis.
Xu YX; Ashline D; Liu L; Tassa C; Shaw SY; Ravid K; Layne MD; Reinhold V; Robbins PW
J Lipid Res; 2015 Feb; 56(2):266-76. PubMed ID: 25528754
[TBL] [Abstract][Full Text] [Related]
6. Oxidized LDL binding to a macrophage-secreted extracellular matrix.
Kaplan M; Aviram M
Biochem Biophys Res Commun; 1997 Aug; 237(2):271-6. PubMed ID: 9268699
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of abdominal aortic aneurysms: possible role of differential production of proteoglycans by smooth muscle cells.
Melrose J; Whitelock J; Xu Q; Ghosh P
J Vasc Surg; 1998 Oct; 28(4):676-86. PubMed ID: 9786264
[TBL] [Abstract][Full Text] [Related]
8. The role of vascular-derived perlecan in modulating cell adhesion, proliferation and growth factor signaling.
Lord MS; Chuang CY; Melrose J; Davies MJ; Iozzo RV; Whitelock JM
Matrix Biol; 2014 Apr; 35():112-22. PubMed ID: 24509440
[TBL] [Abstract][Full Text] [Related]
9. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
Vischer P; Feitsma K; Schön P; Völker W
Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
[TBL] [Abstract][Full Text] [Related]
10. Peroxynitrite modifies the structure and function of the extracellular matrix proteoglycan perlecan by reaction with both the protein core and the heparan sulfate chains.
Kennett EC; Rees MD; Malle E; Hammer A; Whitelock JM; Davies MJ
Free Radic Biol Med; 2010 Jul; 49(2):282-93. PubMed ID: 20416372
[TBL] [Abstract][Full Text] [Related]
11. Binding of platelet-derived growth factor and low density lipoproteins to glycosaminoglycan species produced by human arterial smooth muscle cells.
Fager G; Camejo G; Olsson U; Ostergren-Lundén G; Lustig F; Bondjers G
J Cell Physiol; 1995 May; 163(2):380-92. PubMed ID: 7706380
[TBL] [Abstract][Full Text] [Related]
12. Induction of synthesis of a large heparan sulfate proteoglycan, perlecan, by thrombin in cultured human coronary smooth muscle cells.
Yamamoto C; Wakata T; Fujiwara Y; Kaji T
Biochim Biophys Acta; 2005 Feb; 1722(1):92-102. PubMed ID: 15716125
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein modulation of subendothelial heparan sulfate proteoglycans (perlecan) and atherogenicity.
Pillarisetti S
Trends Cardiovasc Med; 2000 Feb; 10(2):60-5. PubMed ID: 11150731
[TBL] [Abstract][Full Text] [Related]
14. Hemostatic properties and serum lipoprotein binding of a heparan sulfate proteoglycan from bovine aorta.
Vijayagopal P; Srinivasan SR; Radhakrishnamurthy B; Berenson GS
Biochim Biophys Acta; 1983 Jul; 758(1):70-83. PubMed ID: 6222769
[TBL] [Abstract][Full Text] [Related]
15. Membrane-anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form.
Yeaman C; Rapraeger AC
J Cell Physiol; 1993 Nov; 157(2):413-25. PubMed ID: 8227171
[TBL] [Abstract][Full Text] [Related]
16. Role of macrophage glycosaminoglycans in the cellular catabolism of oxidized LDL by macrophages.
Kaplan M; Williams KJ; Mandel H; Aviram M
Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):542-53. PubMed ID: 9555859
[TBL] [Abstract][Full Text] [Related]
17. Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase.
Mulder M; Lombardi P; Jansen H; van Berkel TJ; Frants RR; Havekes LM
J Biol Chem; 1993 May; 268(13):9369-75. PubMed ID: 8387492
[TBL] [Abstract][Full Text] [Related]
18. Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix.
Pillarisetti S; Paka L; Obunike JC; Berglund L; Goldberg IJ
J Clin Invest; 1997 Aug; 100(4):867-74. PubMed ID: 9259586
[TBL] [Abstract][Full Text] [Related]
19. Lead inhibits the core protein synthesis of a large heparan sulfate proteoglycan perlecan by proliferating vascular endothelial cells in culture.
Fujiwara Y; Kaji T
Toxicology; 1999 Apr; 133(2-3):159-69. PubMed ID: 10378482
[TBL] [Abstract][Full Text] [Related]
20. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN
Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
